Dr Daniel R Rasmussen, DO | |
100 Mac Ln, Pierre, SD 57501-3391 | |
(605) 224-5901 | |
Not Available |
Full Name | Dr Daniel R Rasmussen |
---|---|
Gender | Male |
Speciality | Physical Medicine And Rehabilitation |
Experience | 18 Years |
Location | 100 Mac Ln, Pierre, South Dakota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023208907 | NPI | - | NPPES |
6634200 | Medicaid | SD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 51027 (Wisconsin) | Secondary |
208100000X | Physical Medicine & Rehabilitation | 8043 (South Dakota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Avera St Mary's Hospital | Pierre, SD | Hospital |
Avera Hand County Memorial Hospital And Clinic | Miller, SD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Avera St Marys | 0143134965 | 84 |
News Archive
A combination of exposure to broad-spectrum antibiotics and having a platelet count below 50,000/mm3 significantly increases a low-to-normal–weight infant's chance for developing invasive candidiasis, report researchers.
As Republican leaders unveiled a plan to avert a government shutdown, they faced the challenge of building support for the proposal within their own ranks because it does not defund the health law. Some within the caucus reacted with skepticism.
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced the presentation of Phase III clinical and pre-clinical data, which collectively demonstrate that once-daily oral laquinimod modulates the pathological processes of multiple sclerosis to impact disease activity, disability progression and brain volume loss.
Researchers in the UK have reported the protocol for a longitudinal study investigating the risk of adverse physical and mental health outcomes related to coronavirus disease 2019 (COVID-19) among healthcare workers from different ethnic groups.
› Verified 7 days ago
Entity Name | Avera Mckennan |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003389206 PECOS PAC ID: 0345157103 Enrollment ID: O20031110000117 |
News Archive
A combination of exposure to broad-spectrum antibiotics and having a platelet count below 50,000/mm3 significantly increases a low-to-normal–weight infant's chance for developing invasive candidiasis, report researchers.
As Republican leaders unveiled a plan to avert a government shutdown, they faced the challenge of building support for the proposal within their own ranks because it does not defund the health law. Some within the caucus reacted with skepticism.
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced the presentation of Phase III clinical and pre-clinical data, which collectively demonstrate that once-daily oral laquinimod modulates the pathological processes of multiple sclerosis to impact disease activity, disability progression and brain volume loss.
Researchers in the UK have reported the protocol for a longitudinal study investigating the risk of adverse physical and mental health outcomes related to coronavirus disease 2019 (COVID-19) among healthcare workers from different ethnic groups.
› Verified 7 days ago
Entity Name | Avera St Marys |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669457180 PECOS PAC ID: 0143134965 Enrollment ID: O20040225000579 |
News Archive
A combination of exposure to broad-spectrum antibiotics and having a platelet count below 50,000/mm3 significantly increases a low-to-normal–weight infant's chance for developing invasive candidiasis, report researchers.
As Republican leaders unveiled a plan to avert a government shutdown, they faced the challenge of building support for the proposal within their own ranks because it does not defund the health law. Some within the caucus reacted with skepticism.
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced the presentation of Phase III clinical and pre-clinical data, which collectively demonstrate that once-daily oral laquinimod modulates the pathological processes of multiple sclerosis to impact disease activity, disability progression and brain volume loss.
Researchers in the UK have reported the protocol for a longitudinal study investigating the risk of adverse physical and mental health outcomes related to coronavirus disease 2019 (COVID-19) among healthcare workers from different ethnic groups.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daniel R Rasmussen, DO 100 Mac Lane, Avera Medical Group Pierre, Pierre, SD 57501 Ph: (605) 224-7070 | Dr Daniel R Rasmussen, DO 100 Mac Ln, Pierre, SD 57501-3391 Ph: (605) 224-5901 |
News Archive
A combination of exposure to broad-spectrum antibiotics and having a platelet count below 50,000/mm3 significantly increases a low-to-normal–weight infant's chance for developing invasive candidiasis, report researchers.
As Republican leaders unveiled a plan to avert a government shutdown, they faced the challenge of building support for the proposal within their own ranks because it does not defund the health law. Some within the caucus reacted with skepticism.
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced the presentation of Phase III clinical and pre-clinical data, which collectively demonstrate that once-daily oral laquinimod modulates the pathological processes of multiple sclerosis to impact disease activity, disability progression and brain volume loss.
Researchers in the UK have reported the protocol for a longitudinal study investigating the risk of adverse physical and mental health outcomes related to coronavirus disease 2019 (COVID-19) among healthcare workers from different ethnic groups.
› Verified 7 days ago